AI Revolutionizes Prostate Cancer Detection in Routine CT Scans
RMIT University in Melbourne has developed an artificial intelligence (AI) detector that could revolutionize prostate cancer detection. The technology, detailed in a study published in Scientific Reports, could identify cancerous growths in routine CT scans, enabling earlier diagnosis.
The AI detector, developed by a multi-disciplinary team, outperforms radiologists in detecting prostate cancer in CT scans of asymptomatic patients. It adapts to different imaging machines and improves its accuracy with each scan. Currently, CT imaging is not widely used for cancer screening due to high radiation doses. However, this AI technology could enable cancer checks during routine scans for other issues.
The team is seeking commercial partners to integrate the AI checker with hospital equipment for possible clinical trials. They aim to collaborate with HeraMED and the Digital Health Cooperative Research Centre (CRC) to develop software for MRI and DEXA machines. Additionally, they plan to conduct clinical studies focusing on AI-supported risk analysis and predictive models for high-risk pregnancies, with a proof-of-concept expected in 2026.
Prostate cancer is the most diagnosed cancer and a leading cause of death by cancer in Australian men. Early detection is crucial for successful treatment, but many men avoid diagnosis tests. This AI program could significantly improve prostate cancer detection rates, potentially saving lives.
